featured
| Topic | Replies | Views | Activity | |
|---|---|---|---|---|
| Public consultation on current regulatory testing requirements for medicines and opportunities for the implementation of NAMs |
|
1 | 26 | April 14, 2025 |
| How can the lack of formal documentation in patient involvement activities be addressed? |
|
4 | 85 | March 11, 2025 |
| Difference Orphan designation and marketing authorisation |
|
1 | 42 | February 4, 2025 |